Kinnate Biopharma Inc. Debt to Equity Ratio 2021-2023 | KNTE
Current and historical debt to equity ratio values for Kinnate Biopharma Inc. (KNTE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Kinnate Biopharma Inc. debt/equity for the three months ending December 31, 2023 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-12-31 |
$0.01B |
$0.16B |
0.09 |
2023-09-30 |
$0.02B |
$0.17B |
0.11 |
2023-06-30 |
$0.02B |
$0.20B |
0.09 |
2023-03-31 |
$0.02B |
$0.22B |
0.10 |
2022-12-31 |
$0.06B |
$0.22B |
0.25 |
2022-09-30 |
$0.05B |
$0.25B |
0.22 |
2022-06-30 |
$0.05B |
$0.27B |
0.18 |
2022-03-31 |
$0.05B |
$0.30B |
0.18 |
2021-12-31 |
$0.05B |
$0.32B |
0.15 |
2021-09-30 |
$0.05B |
$0.34B |
0.13 |
2021-06-30 |
$0.04B |
$0.36B |
0.12 |
2021-03-31 |
$0.01B |
$0.38B |
0.02 |
2020-12-31 |
$0.01B |
$0.39B |
0.02 |
2020-09-30 |
$0.00B |
|
0.00 |
2020-06-30 |
$0.00B |
|
0.00 |
2020-03-31 |
$0.00B |
|
0.00 |